|
1
|
Wu VW and Lam YN: Radiation-induced
temporo-mandibular joint disorder in post-radiotherapy
nasopharyngeal carcinoma patients: Assessment and treatment. J Med
RadiatSci. 63:124–132. 2016. View
Article : Google Scholar
|
|
2
|
He YQ, Xue WQ, Shen GP, Tang LL, Zeng YX
and Jia WH: Household inhalants exposure and nasopharyngeal
carcinoma risk: A large-scale case-control study in Guangdong,
China. BMC Cancer. 15:10222015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ng WT, Choi CW, Lee MC, Chan SH, Yau TK
and Lee AW: Familial nasopharyngeal carcinoma in Hong Kong:
Epidemiology and implication in screening. Fam Cancer. 8:103–108.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mesic JB, Fletcher GH and Goepfert H:
Megavoltage irradiation of epithelial tumors of the nasopharynx.
Int J Radiat Oncol Biol Phys. 7:447–453. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee AW, Poon YF, Foo W, Law SC, Cheung FK,
Chan DK, Tung SY, Thaw M and Ho JH: Retrospective analysis of 5037
patients with nasopharyngeal carcinoma treated during 1976–1985:
Overall survival and patterns of failure. Int J Radiat Oncol Biol
Phys. 23:261–270. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chua DT, Sham JS, Wei WI, Ho WK and Au GK:
The predictive value of the 1997 American joint committee on cancer
stage classification in determining failure patterns in
nasopharyngeal carcinoma. Cancer. 92:2845–2855. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wolden SL, Zelefsky MJ, Kraus DH,
Rosenzweig KE, Chong LM, Shaha AR, Zhang H, Harrison LB, Shah JP
and Pfister DG: Accelerated concomitant boost radiotherapy and
chemotherapy for advanced nasopharyngeal carcinoma. J ClinOncol.
19:1105–1110. 2001. View Article : Google Scholar
|
|
8
|
Takemaru K, Fischer V and Li FQ:
Fine-tuning of nuclear-catenin by Chibby and 14-3-3. Cell cycle.
8:210–213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takemaru K, Yamaguchi S, Lee YS, Zhang Y,
Carthew RW and Moon RT: Chibby, a nuclear beta-catenin-associated
antagonist of the Wnt/Wingless pathway. Nature. 422:905–909. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li FQ, Mofunanya A, Harris K and Takemaru
K: Chibby cooperates with 14-3-3 to regulate beta-catenin
subcellular distribution and signaling activity. J Cell Biol.
181:1141–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh AM, Li FQ, Hamazaki T, Kasahara H,
Takemaru K and Terada N: Chibby, an antagonist of the
Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation
of murine embryonic stem cells. Circulation. 115:617–626. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li FQ, Singh AM, Mofunanya A, Love D,
Terada N, Moon RT and Takemaru K: Chibby promotes adipocyte
differentiation through inhibition of beta-catenin signaling. Mol
Cell Biol. 27:4347–4354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Love D, Li FQ, Burke MC, Cyge B, Ohmitsu
M, Cabello J, Larson JE, Brody SL, Cohen JC and Takemaru K: Altered
lung morphogenesis, epithelial cell differentiation and mechanics
in mice deficient in the Wnt/β-catenin antagonist Chibby. PLoS One.
5:e136002010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Korinek V, Barker N, Morin PJ, van Wichen
D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive
transcriptional activation by a beta-catenin-Tcf complex in
APC-/-colon carcinoma. Science. 275:1784–1787. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schuierer MM, Graf E, Takemaru K,
Dietmaier W and Bosserhoff AK: Reduced expression of beta-catenin
inhibitor Chibby in colon carcinoma cell lines. World J
Gastroenterol. 12:1529–1535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karakoula K, Suarez-Merino B, Ward S,
Phipps KP, Harkness W, Hayward R, Thompson D, Jacques TS, Harding
B, Beck J, et al: Real-time quantitative PCR analysis of pediatric
ependymomas identifies novel candidate genes including TPR at 1q25
and CHIBBY at 22q12-q13. Genes Chromosomes Cancer. 47:1005–1022.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fischer V, Brown-Grant DA and Li FQ:
Chibby suppresses growth of human SW480 colon adenocarcinoma cells
through inhibition of β-catenin signaling. J Mol Signal. 7:62012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mancini M, Leo E, Takemaru K, Campi V,
Borsi E, Castagnetti F, Gugliotta G, Santucci MA and Martinelli G:
Chibby drives β catenin cytoplasmic accumulation leading to
activation of the unfolded protein response in BCR-ABL1+ cells.
Cell Signal. 25:1820–1827. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J and Zhu XZ: Introduction of WHO
classification of tumours of soft tissue, the fourth edition.
Zhonghua Bing Li XueZaZhi. 42:363–365. 2013.(In Chinese).
|
|
21
|
Jo VY and Fletcher CD: WHO classification
of soft tissue tumours: An update based on the 2013 (4th) edition.
Pathology. 46:95–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mattern J, Koomagi R and Volm M:
Biological characterization of subgroups of squamous cell lung
carcinomas. Clin Cancer Res. 5:1459–1463. 1999.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gad S, Teboul D, Lièvre A, Goasguen N,
Berger A, Beaune P and Laurent-Puig P: Is the gene encoding Chibby
implicated as a tumour suppressor in colorectal cancer? BMC Cancer.
4:312004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev OncolHematol. 99:141–149.
2016. View Article : Google Scholar
|
|
26
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takahashi-Yanaga F and Kahn M: Targeting
Wnt signaling: Can we safely eradicate cancer stem cells? Clin
Cancer Res. 16:3153–3162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang D, Zhang M and Gold B: Origin of
Somatic mutations in β-catenin versus adenomatous polyposis coli in
colon cancer: Random mutagenesis in animal models versus nonrandom
mutagenesis in humans. Chem Res Toxicol. 30:1369–1375. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Majidinia M, Aghazadeh J,
Jahanban-Esfahlani R and Yousefi B: The roles of Wnt/β-catenin
pathway in tissue development and regenerative medicine. J Cell
Physiol. Nov 18–2017.(Epub ahead of print). View Article : Google Scholar
|
|
31
|
Polakis P: The many ways of Wnt in cancer.
CurrOpin Genet Dev. 17:45–51. 2007. View Article : Google Scholar
|
|
32
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shtutman M, Zhurinsky J, Simcha I,
Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1
gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad
Sci USA. 96:pp. 5522–5527. 1999; View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren G, Zhao DA, Xu J and Li BA: Expression
of CBY and methylation of CBY at promoter region in human laryngeal
squamous cell carcinoma. Tumori. 101:215–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brabletz T, Jung A, Hermann K, Günther K,
Hohenberger W and Kirchner T: Nuclear overexpression of the
oncoprotein beta-catenin in colorectal cancer is localized
predominantly at the invasion front. Pathol Res Pract. 194:701–704.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Monin MB, Krause P, Stelling R, Bocuk D,
Niebert S, Klemm F, Pukrop T and Koenig S: The anthelmintic
niclosamide inhibits colorectal cancer cell lines via modulation of
the canonical and noncanonical Wnt signaling pathway. J Surg Res.
203:193–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Davidson G, Shen J, Huang YL, Su Y,
Karaulanov E, Bartscherer K, Hassler C, Stannek P, Boutros M and
Niehrs C: Cell cycle control of wnt receptor activation. Dev Cell.
17:788–799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Drees F, Pokutta S, Yamada S, Nelson WJ
and Weis WI: Alpha-catenin is a molecular switch that binds
E-cadherin-beta-catenin and regulates actin-filament assembly.
Cell. 123:903–915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
